Identifification of a novel LDLR-RET Fusion in Lung Adenocarcinoma

ConclusionsThis novel form of RET fusion in NSCLC is reported for the first time worldwide, offering a new treatment option for the patient with the possibility of using RET-selective inhibitors.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research